Exploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging

NCT06460077 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-04-16

No results posted yet for this study

Summary

This is an open, follow-up study to compare the performance of three critical imaging methods to detect chronic active lesions in Multiple Sclerosis (MS) in vivo.

Conditions

Sponsors & Collaborators

  • Turku University Hospital

    lead OTHER_GOV

Principal Investigators

  • Laura Airas, MD,Professor · Turku University Hospital, division of clinical neurosciences

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-03
Primary Completion
2028-06-30
Completion
2028-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06460077 on ClinicalTrials.gov